Korytkova 2, 1000 Ljubljana
+386 1 543 7103
tajnistvo.patologija@mf.uni-lj.si
Osveži iskanje
Prikaz primera
Pavsic N, Dolenc-Strazar Z, Cerne Cercek A, Klokocovnik T, Prokselj K.
Coronary Artery Embolism From a Blood Cyst of the Mitral Valve.
Heart, Lung and Circulation 2017; 26, e118-1120.
2
Raziskovalni
Boštjančič E, Hauptman N, Grošelj A, Glavač D, Volavšek M.
Expression, mutation, and amplification status of EGFR and its correlation with five miRNAs in salivary gland tumours.
Biomed Res Int 2017; 2017: 9150402.
2.5
Zidar N, Boštjančič E, Malgaj M, Gale N, Dovšak T, Didanovič V.
The role of epithelial-mesenchymal transition in squamous cell carcinoma of the oral cavity.
Virchows Arch 2018; 472: 237-45.
2.8
Matjašič A, Tajnik M, Boštjančič E, Popović M, Matos B, Glavač D.
Identifying novel glioma-associated noncoding RNAs by their expression profiles.
Int J Genomics 2017; 2017: 2312318.
2.4
Bolha L, Ravnik-Glavač M, Glavač D.
Circular RNAs: biogenesis, function, and a role as possible cancer biomarkers.
International Journal of Genomics 2017, 2017:7243968. doi: 10.1155/2017/7243968: 1-19.
Pregledni
Hauptman N, Glavač D.
Colorectal cancer blood-based biomarkers.
Gastroenterology Research and Practice 2017; 2017: 1-11.
1.9
Štrafela P, Pleško J, Magdič J, Koritnik B, Zupan A, Glavač D, Bresjanac M, Popovič M.
Familial tauopathy with P364S MAPT mutation : clinical course, neuropathology and ultrastructure of neuronal tau inclusions.
Neuropathology and applied neurobiology 2017, doi: 10.1111/nan.12456.
5.3
Long noncoding RNAs as biomarkers in cancer.
Disease Markers 2017; 2017:7243968. doi: 10.1155/2017/7243968, 1-14.
Urlep Ž, Lorbek G, Perše M, et al.
Disrupting Hepatocyte Cyp51 from Cholesterol Synthesis Leads to Progressive Liver Injury in the Developing Mouse and Decreases RORC Signalling.
ci Rep 2017; 7: 40775.
4.3
Kojc N, Aleš Rigler A, Mlinšek G, Kovač D, Ferluga D, Arnol M.
Outcome of Polyomavirus nephropathy in renal transplant patients – a single center experience.
Clin Nephrol 2017 Supplement 1; 88:109-114.
1.1
Accessibility Tools